Dexcom | DXCM - 股本和储备



金融业
股票价格
USD
资产
USD 6.63B
现金及等价物
USD 1.12B
销售成本
USD 441.6M
流动资产
USD 4.33B
流动负债
USD 2.22B
债务
USD 1.24B
EBIT
USD 255.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.56
股本和储备
USD 2.96B
销售毛利
USD 750.3M
债务利息支出
USD 4.2M
利息收入
USD 23.5M
贷款资金
USD 1.3B
市值
USD 27.13B
净收入
USD 199.5M
营业费用
USD 936.6M
营业利润
USD 255.3M
普通股股本
USD 385.9M
PE价格收益
24.73
税前利润
USD 340.7M
销售收入
USD 1.19B
销售和管理费用
USD 349.7M
股票
USD 693.6M
贸易债权人
USD 1.94B
应收帐款人
USD 1.09B


股本和储备 更改 日
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.15B 100.27M 2026-03
AtriCure USD 491.69M 242K 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
J&J USD 81.19B 358M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Solventum Corp USD 4.97B 80M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
West Pharmaceutical Services USD 2.99B 185.6M 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03